Articles tagged "Kidney transplantation"

2019 American Transplant Congress
Impact of Delayed Graft Function on Allograft Survival in DCD versus DBD Kidneys
T. Ishaque, A. B. Massie, J. Ruck, C. Holscher, J. G. Wang, D. L. Segev
Surgery, Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: Several single-center studies have suggested no link between delayed graft function (DGF) and graft survival in recipients of donation after cardiac death (DCD) kidneys,…
2019 American Transplant Congress
Health Utility And Social Distress In Kidney Transplant (KT) Recipients
S. Macanovic¹, D. Li¹, B. Liao¹, I. Escudero¹, V. Shah², A. Nagee², A. Che², R. Khairalla², M. Novak³, I. Mucsi¹
¹Division of Nephrology and Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada, ²University of Western Ontario, London, ON, Canada, ³Centre for Mental Health, University Health Network, Toronto, ON, Canada
*Purpose: Preference-based measures of health-related quality of life (HRQOL) or health utility, such as the EuroQol-5D5L (EQ5), cover multiple health domains and are combined into…
2019 American Transplant Congress
Retroperitoneoscopic Native Nephrectomy in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease
K. Hotta¹, D. Iwami², J. Furumido², K. Morita³, T. Tanabe⁴, T. Mochizuki⁴, H. Higuchi², N. Iwahara², T. Abe², K. Kanagawa⁴, N. Shinohara²
¹Hokkaido University Hospital, Sapporo, Japan, ²Urology, Hokkaido University Hospital, Sapporo, Japan, ³Urology, Kushiro City General Hospital, Kushiro, Japan, ⁴Urology, Asahikawa City General Hospital, Asahikawa, Japan
*Purpose: Autosomal dominant polycystic kidney disease (ADPKD) leads to end stage kidney disease (ESKD) and the need for kidney transplantation (KTX). Native nephrectomy is required…
2019 American Transplant Congress
The Crucial Role of Molecular Microscope in the Interpretation of Ambiguous Lesions Such as Banff Borderline Changes and Tubulo-Interstitial Inflammation Accompanying PVAN
D. Deborska-Materkowska¹, A. Perkowska-Ptasinska¹, M. Ciszek¹, P. F. Halloran², M. Myslak³
¹Warsaw Medical University, Warsaw, Poland, ²ATAGC, University of Alberta, Edmonton AB, AB, Canada, ³Pomeranian Medical University, Szczecin, Poland
*Purpose: Anti-rejection treatment implementation is highly dependent on morphologic lesions interpretation based on Banff classification. Unfortunately, some light microscopic phenotypes are ambiguous which constricts the…
2019 American Transplant Congress
Successful Kidney Transplant Improves Glucose Tolerance – A Paradoxical Report From A Single Center
A. Mitsuke, H. Harada, H. Higuchi, N. Fukuzawa, H. Tanaka, T. Hirano, T. Sekii
Kidney Transplantation Surgery, Sapporo City General Hospital, Sapporo, Japan
*Purpose: Kidney recipients tend to impair glucose tolerance because of several factors such as post-operative obesity, and chronic exposure of some diabetogenic immunosuppressants like calcineurin…
2019 American Transplant Congress
Transport Medium Fluid Cultures in Paediatric Renal Transplantation: Are We Ready to Make a Consensus on Prophylaxis?
D. Furnell¹, S. Boyle¹, N. Kessaris², S. D. Marks¹, J. Stojanovic¹
¹Nephrology, Great Ormond Street Hospital, London, United Kingdom, ²Transplantation, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
*Purpose: To establish the rate of positive transport medium fluid cultures and sensitivity to antibiotics in paediatric renal transplant recipients.*Methods: We analysed the electronic records…
2019 American Transplant Congress
Protocol Cidofovir for Refractory Polyomavirus Associated Nephropathy in Kidney Transplant Recipients
J. Clark, A. Haririan
University of Maryland Medical Center, Baltimore, MD
*Purpose: Dose-limiting nephrotoxicity has historically precluded the use of cidofovir for polyomavirus associated nephropathy (PVAN). With incidence of BK viremia in kidney transplant recipients increasing…
2019 American Transplant Congress
Evaluating Potentially Inappropriate Prescribing in Older Kidney Transplant Recipients
L. DeVietro¹, B. Richardson², E. A. Cohen³, A. H. Toledo⁴, E. Marin⁵, K. R. Szempruch⁶
¹University of St. Joseph School of Pharmacy, Hartford, CT, ²University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, ³Pharmacy, Yale New Haven Hospital, New Haven, CT, ⁴Surgery-Transplant, University of North Carolina Medical Center, Chapel Hill, NC, ⁵Nephrology, Yale New Haven Hospital, New Haven, CT, ⁶Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC
*Purpose: While the Beers criteria (BC) and STOPP criteria (SC) have been validated in several patient populations to reduce medication use leading to adverse drug…
2019 American Transplant Congress
Gene Expression Profiles in CD8+ T Cells in Chronic Antibody-Mediated Rejection (CAMR) of Kidney Transplantation
P. Pontrelli¹, F. Rascio², M. Accetturo¹, G. Castellano¹, S. Simone¹, G. Stallone², L. Gesualdo¹, G. Grandaliano²
¹Department of Emergency, and Organ Transplantation, Nephrology, Dialysis and Transplantation Unit, University of Bari, Bari, Italy, ²Dept. of Surgical and Medical Sciences, Nephrology Unit, University of Foggia, Foggia, Italy
*Purpose: CAMR is the main cause of chronic graft injury and subsequent graft loss. Most of the studies on the subject focused their attention to…
2019 American Transplant Congress
How Much Does Graft Function Cost Us? A Financial Analysis of Delayed Graft Function in Kidney Transplant Recipients
A. Yaldo, I. Bajjoka, C. Crombez, M. Abouljoud
Henry Ford Transplant Institute, Detroit, MI
*Purpose: Kidney transplant recipients (KTR) who receive dialysis post-transplant experience worse outcomes during the first year post-transplant. Whether KTR discharged with elevated levels of serum…